429 related articles for article (PubMed ID: 30235809)
1. Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application.
Tsai CH; Wang PY; Lin IC; Huang H; Liu GS; Tseng CL
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30235809
[TBL] [Abstract][Full Text] [Related]
2. A Mini-review on New Developments in Nanocarriers and Polymers for Ophthalmic Drug Delivery Strategies.
Sharma Y; Patel P; Kurmi BD
Curr Drug Deliv; 2024; 21(4):488-508. PubMed ID: 37143264
[TBL] [Abstract][Full Text] [Related]
3. Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics.
Datta D; Priyanka Bandi S; Colaco V; Dhas N; Siva Reddy DV; Vora LK
Int J Pharm; 2024 Jun; 658():124192. PubMed ID: 38703931
[TBL] [Abstract][Full Text] [Related]
4. Drug delivery to the eye: what benefits do nanocarriers offer?
Joseph RR; Venkatraman SS
Nanomedicine (Lond); 2017 Mar; 12(6):683-702. PubMed ID: 28186436
[TBL] [Abstract][Full Text] [Related]
5. Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.
Shree D; Patra CN; Sahoo BM
Pharm Nanotechnol; 2024; 12(3):229-250. PubMed ID: 37587812
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable Nanoparticles: A Recent Approach and Applications.
Patil V; Patel A
Curr Drug Targets; 2020; 21(16):1722-1732. PubMed ID: 32938346
[TBL] [Abstract][Full Text] [Related]
7. Emphasis on Nanostructured Lipid Carriers in the Ocular Delivery of Antibiotics.
Singh CP; Rai PK; Kumar M; Tiwari V; Tiwari A; Sharma A; Sharma K
Pharm Nanotechnol; 2024; 12(2):126-142. PubMed ID: 37519002
[TBL] [Abstract][Full Text] [Related]
8. Natural biodegradable polymers based nano-formulations for drug delivery: A review.
George A; Shah PA; Shrivastav PS
Int J Pharm; 2019 Apr; 561():244-264. PubMed ID: 30851391
[TBL] [Abstract][Full Text] [Related]
9. Nanotechnology for Topical Drug Delivery to the Anterior Segment of the Eye.
Vaneev A; Tikhomirova V; Chesnokova N; Popova E; Beznos O; Kost O; Klyachko N
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830247
[TBL] [Abstract][Full Text] [Related]
10. A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances.
Wang R; Gao Y; Liu A; Zhai G
J Drug Target; 2021 Aug; 29(7):687-702. PubMed ID: 33474998
[TBL] [Abstract][Full Text] [Related]
11. Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies.
Mandal A; Bisht R; Rupenthal ID; Mitra AK
J Control Release; 2017 Feb; 248():96-116. PubMed ID: 28087407
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticles for ocular drug delivery: modified and non-modified chitosan as a promising biocompatible carrier.
Pontillo ARN; Detsi A
Nanomedicine (Lond); 2019 Jul; 14(14):1889-1909. PubMed ID: 31274373
[TBL] [Abstract][Full Text] [Related]
13. Polysaccharide-Based Nanocarriers for Ocular Drug Delivery.
Formica ML; Calles JA; Palma SD
Curr Pharm Des; 2015; 21(33):4851-68. PubMed ID: 26290208
[TBL] [Abstract][Full Text] [Related]
14. Ophthalmic applications of lipid-based drug nanocarriers: an update of research and patenting activity.
Pignatello R; Carbone C; Puglia C; Offerta A; Bonina FP; Puglisi G
Ther Deliv; 2015; 6(11):1297-318. PubMed ID: 26608630
[TBL] [Abstract][Full Text] [Related]
15. Promising Polymeric Drug Carriers for Local Delivery: The Case of
Okur NÜ; Yağcılar AP; Siafaka PI
Curr Drug Deliv; 2020; 17(8):675-693. PubMed ID: 32510291
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone Butyrate.
Yang X; Trinh HM; Agrahari V; Sheng Y; Pal D; Mitra AK
AAPS PharmSciTech; 2016 Apr; 17(2):294-306. PubMed ID: 26085051
[TBL] [Abstract][Full Text] [Related]
17. Poly(ortho ester) nanoparticles targeted for chronic intraocular diseases: ocular safety and localization after intravitreal injection.
Li H; Palamoor M; Jablonski MM
Nanotoxicology; 2016 Oct; 10(8):1152-9. PubMed ID: 27108911
[TBL] [Abstract][Full Text] [Related]
18. A Comprehensive Review on the Role of Polymers in Ocular Drug Delivery.
Paramjot ; Wadhwa S; Sharma A; Singh SK; Vishwas S; Kumar R; Singh S; Dua K; Chellappan DK; Gupta G
Curr Drug Deliv; 2024; 21(1):16-37. PubMed ID: 36627785
[TBL] [Abstract][Full Text] [Related]
19. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
[TBL] [Abstract][Full Text] [Related]
20. A Novel Method for Preparing Surface-Modified Fluocinolone Acetonide Loaded PLGA Nanoparticles for Ocular Use: In Vitro and In Vivo Evaluations.
Salama AH; Mahmoud AA; Kamel R
AAPS PharmSciTech; 2016 Oct; 17(5):1159-72. PubMed ID: 26589410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
